People with amyotrophic lateral sclerosis (ALS) who get a feeding tube placed after losing a lot of weight are…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
The HEALEY ALS platform trial, which is simultaneously testing multiple potential treatments for amyotrophic lateral sclerosis (ALS), is…
The U.S. Food and Drug Administration (FDA) signaled that it may be willing to consider granting accelerated approval to…
People with mutations in the C9ORF72 gene who develop amyotrophic lateral sclerosis (ALS) show signs of damage to certain…
Long-term treatment with the cell therapy NurOwn (debamestrocel) was found to significantly extend survival in people with amyotrophic…
Neurosense Therapeutics will meet with the U.S. Food and Drug Administration (FDA) Nov. 6 to discuss plans for a Phase…
Treatment with Radicava ORS (edaravone) significantly slowed declines in physical function and improved survival outcomes for people with…
Neither memantine nor trazodone, two medications approved to treat other conditions, was able to slow disease progression in people with…
The Scott-Morgan Foundation (SMF), a nonprofit that’s pioneering assistive technology innovation, will lead a new initiative using artificial intelligence…
People with higher levels of certain metals in their blood and urine are more likely to develop amyotrophic lateral…